Searched for
SKIN CANCER VACCINES
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%The official kickoff of the Q4 earnings season happens when a large IT company announces its results, although the quarter’s business updat...
- Moderna shares up 2% as skin cancer vaccine shows sustained benefit in five-year follow-upModerna and Merck said on Tuesday their experimental personalized vaccine continued to cut the risk of death or recurrence of the most dea...
- COVID-19 vaccines may help some cancer patients fight tumorsNew research suggests COVID-19 mRNA vaccines could help cancer patients. Those with advanced lung or skin cancer who received Pfizer or Mod...
- Cancer cure? Russia commences human trials of revolutionary personalized cancer vaccineRussia's Gamaleya Center, famed for Sputnik V, will initiate human trials for a personalized mRNA melanoma vaccine by late 2025. This innov...
- Why is cancer becoming shockingly common among Indians in their 20s and 30s? Oncologists blame this virusCancer doctors in India are raising concerns about rising HPV-related cancers among young adults. Cases of cervical, oral, and throat cance...
- Russian President Vladimir Putin claims significant progress made towards Cancer vaccinesRussian President Vladimir Putin announced that Russian scientists are close to developing cancer vaccines, potentially revolutionizing can...
- Moderna cancer vaccine trial begins in UK, scientists hopeful of 'dawn of a new age of treatments'Cancer patients in the UK are part of a global trial for the mRNA therapy mRNA-4359. The phase 1/2 clinical trial, sponsored by Moderna, ai...
- Anti-cancer jab taking 7 minutes to administer rolled out in EnglandThe UK's NHS has rolled out a new anti-cancer jab that can reduce treatment time by three quarters. The seven-minute injection, which is ad...
- The next big advance in cancer treatment could be a vaccineResearchers predict that the next big advance in cancer treatment will be the development of vaccines to shrink tumors and stop cancer from...
- Scientifically engineered white blood cells can stall cancerous growth: StudyMacrophages, a type of white blood cell, immediately engulf and destroy invaders such as bacteria, viruses, and even implants to remove the...
- Vaccine Printer: Here's how it works and other key detailsMIT researchers have developed first-of-its-kind Mobile Vaccine Printer to help combat outbreaks.
- Cancer vaccines are being developed using tech similar to that used for Covid shotsDecades before Covid vaccines, scientists had been working on messenger ribonucleic acid (mRNA) vaccines targeting cancer.
- mRNA technology-based Cancer vaccine boosts chances of survival: ModernaData revealed that using Merck's immunotherapy drug in combination with high-risk patients decreased their risk of dying.
- Quit smoking, wear sunscreen: 5 things smart people must do in their 20s & 30s to reduce cancer riskSmoking is linked to 14 other types of cancer, including mouth & throat cancer.
- Amazon developing breast & skin cancer vaccines; e-tail giant gears up for Phase 1 trialsThe e-tail giant has partnered with the US-based Fred Hutchinson Cancer Center.
- Moderna vaccine antibodies last at least 6 months; lung transplant can save some COVID-19 survivorsEarlier this month, Pfizer Inc and partner BioNTech SE said their vaccine using similar messenger RNA (mRNA) technology remained highly eff...
- World Hepatitis Day: Facts most people don't knowIn some cases, the chronic infections leave behind long-term health implications.
- Soon, personalised ovarian cancer vaccinesDr Angela Kueck, a gynecological oncologist at UConn Health, will run the initial clinical study, once it is approved by the US Food and Dr...
- Novartis revamps pharma world with mega-deals with GSK, Eli LillyThe Swiss drugmaker said it would divest its vaccines business, excluding flu, to GSK for $7.1 million plus royalties.
Load More
